Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Aalborg – page 27

330 clinical trials in Aalborg, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Aalborg at a glance
330
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

330 trials in Aalborg

Open in trial search

Endometrial cancer

Not recruiting

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Biogen Idec Research Limited

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Bronchiectasis

Not recruiting

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Rectal cancer

Not recruiting

Study Comparing Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin to Standard Treatment for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Sjaelland
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Alemtuzumab
  • Sponsor:St. Anna Childrens Cancer Research Institute GmbH

Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Norwegian University Of Science And Technolology

Cardiac arrest

Not recruiting

Study on the Effects of Dexamethasone and Olanzapine in Patients Resuscitated from Out-of-Hospital Cardiac Arrest

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Olanzapine
  • Sponsor:Rigshospitalet

Study Comparing Subcutaneous and Intravenous Human Normal Immunoglobulin for New Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Region Midtjylland

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Aalborg

What the registry says about research in the country

01 Oncology Studies

Innovative research focusing on endometrial cancer and metastatic prostate cancer treatments. Studies evaluating new therapeutic combinations and investigating cannabidiol's potential in cancer care.

  • Advanced breast cancer therapy evaluation
  • Cancer-related fatigue management
  • Novel drug combinations assessment

Multiple trials exploring targeted therapies and quality of life improvements for cancer patients.

02 Immunology & Infectious Diseases

Comprehensive studies on meningococcal vaccines and chickenpox prevention in children. Research includes RSV prevention and inflammatory conditions.

  • Vaccine immunogenicity studies
  • Chronic rhinosinusitis treatments
  • Plaque psoriasis therapies

Focus on preventive medicine and immune system responses in various age groups.

03 Gastrointestinal & Metabolic Disorders

Investigations into inflammatory bowel diseases including studies on Crohn's Disease and Ulcerative Colitis. Research on opioid-induced bowel dysfunction.

  • Therapeutic drug monitoring
  • Bowel dysfunction treatments
  • Novel therapeutic combinations

Advancing understanding of digestive system disorders and their management.

04 Cardiovascular & Renal Studies

Research on chronic kidney disease treatments and heart failure prevention. Studies examining new approaches for cardiovascular disease management.

  • Heart failure prevention strategies
  • Kidney disease therapies
  • Cardiovascular risk reduction

Innovative approaches to managing complex cardio-renal conditions.

05 Neurological & Psychiatric Research

Studies investigating treatments for amyotrophic lateral sclerosis and dual diagnosis of schizophrenia with alcohol use disorder.

  • ALS treatment development
  • Psychiatric disorder management
  • Neurological disease therapies

Exploring new therapeutic options for complex neurological and psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.